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171 Classical criteria for chronic infection predict the maintenance of
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Chronic infection characteristic of Cystic Fibrosis (CF), determines progressive
pulmonary destruction, mainly caused by Pseudomonas aeruginosa and Staphylo-
coccus aureus. S. aureus is generally the ﬁrst infectious agent.
In this study the authors intended to check if the infection clinically classiﬁed
as chronic among patients followed at the CF Centre of Hospital Santa Maria
(paediatric group: 68 patients), is due to persistence of the same clone, or to
successive infections.
Isolates of S. aureus identiﬁed on microbiological exams of sputum or respiratory
secretions, between May 2005 and April 2006, have been studied (144 isolates from
44 patients).
Isolates have been characterized by antibiotic susceptibility tests and pulsed-ﬁeld gel
electrophoresis (PFGE) and the restriction patterns compared by the Bionumerics
computer program. Twenty different clones were identiﬁed.
Thirty four patients were classiﬁed as having chronic infection, by classical criteria:
at least 3 isolates of S. aureus, during a 6 month period, with a minimal one
month interval. Some of these patients had negative sputum cultures during the
study period. Twenty nine of the chronically infected patients have kept the same
clone during the study. Four other patients, classiﬁed as intermittently infected, also
maintained the same clone.
The results found show the persistence of the same clone during this period of time,
in the majority of the patients, and that clinical classiﬁcation of chronic infection
correlates with persistence of the same clone.
They also point that the current therapeutic protocols for S. aureus infection, are
not effective on eradicating it.
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Introduction: Although MRSA colonization/infection is increasingly found in
patients with CF during the last years, there is controversy regarding the importance
of this organism in CF.
The aim of this study was to determine the epidemiological features of MRSA
airway colonization in our CF patients.
Methods: We undertook a cross-sectional microbiological survey of staphylococcal
organisms from all CF patients attending our CF Unit in 2000 and in 2007.
Results: In 2000, 19 of 56 children (33.9%) had at least one culture of S. aureus, of
whom 4 (21.05%) were taking antistaphylococcal prophylaxis. None of these grew
MRSA. In 2007, 23 of 73 patients (31.5%) had at least on culture of S. aureus,
and 14 of these (60.9%) were taking antistaphylococcal prophylaxis. Four of these
(5.48% of the whole clinic) grew MRSA; all of them were intermittent and were
already taking antistaphylococcal prphylaxis. The mean age of the patients with
MRSA positive cultures was 13.75 (SD: 8.3) years.
Conclusions: Although MRSA prevalence has increased in our CF Unit during the
last 6 years, MRSA colonization is very limited in our clinic and the few patients
who acquire it do not usually become colonized but clear it over time.
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The effect of sputum colonisation with MRSA in CF on lung function and
overall morbidity and mortality remains debatable. However, skin isolation may
be a contraindication to lung transplantation and there are wider cross-infection
implications for others within the hospital environment. Our strict segregation
policy leads to social isolation which may have adverse psychological effects.
Therefore, since 2005 we have offered aggressive MRSA eradication therapy to
patients acquiring a ﬁrst sputum isolate.
Aim: To assess the incidence, prevalence, rate of eradication of ﬁrst isolates and
re-emergence of MRSA at our centre in a 3 year prospective study.
Methods: Asymptomatic patients were offered 6 weeks of Rifampicin and Fusidic
acid po + topical MRSA eradication therapy. If symptomatic, patients also received
IV Teichoplanin for the ﬁrst 2 weeks and if co-colonised with Pseudomonas they
also received IV antipseudomonal antibiotics i.e.beta lactam + aminoglycoside
(Fusidic acid was withheld during this period).
Results: 8/105 (8%) were chronically colonised with MRSA Dec 04 (4 have since
died and in 2 others, MRSA has since been eradicated). Incidence of ﬁrst isolates
in 2005 was 3/143 (2%), in 2006 was 7/161 (4%) and in 2007 was 3/173 (2%). All
13 ﬁrst isolates received eradication therapy, 6 po alone and 7 po and IV treatment.
12 ﬁrst isolates were eradicated with no re-emergence (minimum 3 negative sputums
at monthly intervals). One patient is awaiting sputum conﬁrmation of eradication.
Prevalence in Jan 2008 is 2/171 (1%).
Conclusion: Although the clinical signiﬁcance of single MRSA isolates remains
debatable, our eradication policy has removed both the isolation and social stigma
of MRSA colonisation in a signiﬁcant number of our patients.
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Respiratory tract infection with eventual respiratory failure is the major cause of
morbidity and mortality in cystic ﬁbrosis (CF). Infection with methicillin-resistant
Staphylococcus aureus (MRSA) is a problem. MRSA infection is increasingly found
in patients with CF.
Aims: To determine whether MRSA infection has a deleterious effect on the clinical
status of children with CF.or.not
Methods: 544 children were diagnosed as having cystic ﬁbrosis enrolled in the
Hacettepe University Pediatric Pulmonology Unit. 6 patients with MRSA and 37
MSSA colonisation participated in the study. The patients were followed-up for 3
months period and all of them were treated for MRSA.
Results: A total of 6 patients (5 girls, 1 boy) participated in patient with MRSA
(MRSAP), 37 patients with MSSA (MSSAP) (14 girls, 23 boys) study. The mean
diagnose age as CF were 19 months (2−59 months) in MRSAP and were 56 months
(15 days-260 month) in MSSAP. They were colonised with MRSA at the mean age
of 97 months (48–160 months) and than followed up mean 38 months (22−56
months) in MRSAP and were 96 months (6–204 months) in MSSAP. The mean
BMI were 14.60 in MRSAP and were 17.11 in MSSAP.The mean FEV1 were 46%
(range 25%-63%), and were 66.51 (20–100) in MSSAP. 2 patients died during
the follow-upperiod in MRSAP and 1 patient enterred to the lung transplantation
programme. All of the MSSA.patients were alive. All of the MRSA patients, but
only 27 MSSA patients had bronchectasis. FEV1 were low in MRSA group than
MSSA. The mean last BMI were low in MRSA group than MSSA group.
Conclusion: MRSA infection in children with CF does signiﬁcantly affect res-
piratory function. Children with MRSA require signiﬁcantly more courses of
intravenous antibiotics and have a worse chest x ray appearance.
